10-[2-(3,4-Dimethoxyphenyl)ethylamino]-2-(4-methylphenyl)sulfonyl-2,7-diazatricyclo[6.3.1.04,12]dodeca-1(12),3,7,9-tetraen-11-one | 1049704-13-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: 10-[2-(3,4-Dimethoxyphenyl)ethylamino]-2-(4-methylphenyl)sulfonyl-2,7-diazatricyclo[6.3.1.04,12]dodeca-1(12),3,7,9-tetraen-11-one
• CAS: 1049704-13-3
• 化学式: C₂₇H₂₇N₃O₅S
• 分子量: 505.594
• InChiKey: FKGMEJYFQAQSPR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.2
• 重原子数：
  36
• 可旋转键数：
  8
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.26
• 拓扑面积：
  107
• 氢给体数：
  1
• 氢受体数：
  7

反应信息

• 作为反应物：
  描述：

  10-[2-(3,4-Dimethoxyphenyl)ethylamino]-2-(4-methylphenyl)sulfonyl-2,7-diazatricyclo[6.3.1.04,12]dodeca-1(12),3,7,9-tetraen-11-one 在 甲醇 、 sodium azide 作用下， 反应 48.0h， 以53%的产率得到7-((3,4-dimethoxyphenethyl)amino)-3,4,5,5a-tetrahydropyrrolo[4,3,2-de]quinolin-8(1H)-one
  参考文献：
  名称：

  Azide-Mediated Detosylation of N-Tosylpyrroloiminoquinones and N-Tosylindole-4,7-quinones

  摘要：

  NaN3作为N-甲苯磺酰吡咯并咪诺喹啉和N-甲苯磺酰吲哚-4,7-喹啉脱甲苯磺酰化反应试剂的实用性已经得到了描述。在极性质子惰性溶剂如DMF和DMSO中进行NaN3介导的脱甲苯磺酰化反应。该反应在温和中性条件下进行，并能获得较好的至优异的脱甲苯磺酰化喹啉产率。

  DOI：

  10.1055/s-0028-1083570

文献信息

• Marine Alkalod Makaluvamines and Derivatives Thereof
  申请人：Velu Sadanandan E.

  公开号：US20100144779A1

  公开（公告）日：2010-06-10

  The present disclosure provides compounds based on the marine alkaloid makaluvamine. Described are compounds of the general formula (I) and (II). Also described are pharmaceutical compositions comprising one or more of the compounds of the general formula (I) and (II). The compounds and pharmaceutical compositions described inhibit the growth of several cancer lines, induce apoptosis and cell cycle arrest, display topoisomerase II inhibitory activity and modulate the activity and/or expression of key proteins involved in the regulation of cell growth. Methods of treatment and prevention using the compounds and pharmaceutical compositions described are also provided.
• [EN] MARINE ALKALOID MAKALUVAMINES AND DERIVATIVES THEREOF<br/>[FR] ALCALOÏDES MAKALUVAMINES MARINS ET LEURS DÉRIVÉS
  申请人：UAB RESEARCH FOUNDATION

  公开号：WO2008103483A2

  公开（公告）日：2008-08-28

  [EN] The present disclosure provides compounds based on the marine alkaloid makaluvamine. Described are compounds of the general formula (I) and (II). Also described are pharmaceutical compositions comprising one or more of the compounds of the general formula (I) and (II). The compounds and pharmaceutical compositions described inhibit the growth of several cancer lines, induce apoptosis and cell cycle arrest, display topoisomerase II inhibitory activity and modulate the activity and/or expression of key proteins involved in the regulation of cell growth. Methods of treatment and prevention using the compounds and pharmaceutical compositions described are also provided.
  [FR] La présente invention concerne des composés fondés sur l'alcaloïde makaluvamine marin. Les composés de formule générale (I) et (II) sont décrits. L'invention concerne également des compositions pharmaceutiques comprenant un ou plusieurs des composés de formule générale (I) et (II). Les composés et les compositions pharmaceutiques décrits inhibent la croissance de plusieurs lignées cancéreuses, induisent l'apoptose et stoppent le cycle cellulaire, affichent une activité d'inhibition de la topoisomérase II et modulent l'activité et/ou l'expression de protéines clés impliquées dans la régulation de la croissance cellulaire. L'invention concerne également des procédés de traitement et de prévention qui utilisent les composés et les compositions pharmaceutiques décrits.